Objective: To analyze the relationship between serum soluble B7-H3(sB7-H3) and disease severity, clinical and imaging characteristics in children with Mycoplasma pneumoniae pneumonia(MPP). Methods: A total of 382 hospitalized children under 14 years old diagnosed with MPP in our hospital from January 2018 to June 2022 were collected, and peripheral blood samples were collected within 24 hours after admission. At the same time, 200 children who received elective surgery in our hospital without any evidence of infection were selected as the control group. Plasma of sB7-H3 level and inflammatory cytokines were detected by enzyme linked immunosorbent assay. The clinical features and chest radiographic findings of children with MPP were analyzed. Results: Compared with the control group, the baseline plasma sB7-H3 level in children with MPP was significantly increased(P<0.001), and the baseline plasma sB7-H3 level in children with severe MPP was significantly higher than that in children with mild MPP(P<0.001). Sputum, hypoxemia, tachycardia, pulmonary rurgis, extrapulmonary manifestations, pleural effusion and other clinical symptoms were more common in the subgroup with high level of sB7-H3, and the levels of white blood cell count, platelet count and C-reactive protein were higher(P<0.05). Multivariate Logistic regression analysis showed that elevated baseline plasma sB7-H3 level was an independent risk factor for severe MPP(P<0.05). According the receiver operating characteristic, baseline plasma sB7-H3(AUC: 0.855) was of good value in differentiating mild MPP from severe MPP. In addition, Spearman correlation analysis showed that the baseline plasma sB7-H3 level of MPP children were positively correlated with the duration of fever, duration of antibiotic use, length of hospital stay, inflammatory cytokine γ-interferon, interleukin-17 and granulocytemacrophage colony-stimulating factors(P<0.001). The baseline plasma sB7-H3 level in the consolidation subgroup was significantly higher than that in the non-consolidation subgroup(P<0.001). Conclusion: The baseline plasma sB7-H3 level is generally elevated in children with MPP. High sB7-H3 level indicates a more serious inflammatory response and a higher possibility of pulmonary lobe or segmental consolidation. sB7-H3 can be used as a valuable biomarker to distinguish severe MPP and mild MPP. |
[1] 刘峰.肺炎支原体肺炎与预后相关的临床指标[J].临床儿科杂志,2022,40(4):247-251.
[2] KIM S H,LEE E,SONG E S,et al.Clinical significance of pleural effusion in Mycoplasma pneumoniae pneumonia in children[J].Pathogens,2021,10(9):1075.
[3] FANG K N,WANG J,NI J W.Correlation between Mycoplasma pneumoniae DNA replication level and disease severity in children with severe Mycoplasma pneumoniae pneumonia[J].Chin J Contemp Pediatr,2019,21(9):876-880.
[4] ZHOU W T,JIN W L.B7-H3/CD276: an emerging cancer immunotherapy[J].Front Immunol, 2021,12:1-13.
[5] 吕心路,曹磊,顾洁,等.血浆可溶性B7-H3在原发性胆汁性胆管炎患者中的表达水平及临床预后评价[J].临床检验杂志,2022,40(1):19-22.
[6] ZHANG G,WANG J,KELLY J,et al.B7-H3 augments the inflammatory response and is associated with human sepsis[J].J Immunol,2010,185(6):3677-3684.
[7] CHEN Z,ZHAO X,ZHANG X,et al.Increased concentrations of soluble B7-H3 and interleukin 36 in bronchoalveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia[J].BMC Infect Dis,2016,16:212-217.
[8] Subspecialty Group of Respiratory Diseases,the Society of Pediatrics, Chinese Medical Association,et al.Guidelines for management of community acquired pneumonia in children(the revised edition of 2013)(I)[J].Chin J Pediatr,2013,51(10):745-752.
[9] YANG M,MENG F,GAO M,et al.Cytokine signatures associate with disease severity in children with Mycoplasma pneumoniae pneumonia[J].Sci Rep,2019,9(1):17853-17862.
[10] 景素敬,柳敏,程颖,等.肺炎支原体肺炎儿童血浆SP-D、sB7-H3浓度变化及其与疾病严重程度的相关性研究[J].东南大学学报(医学版),2021,40(3):305-311.
[11] 甄乾娜,张磊,王兴斌.外周血T淋巴细胞亚群和细胞因子在儿童肺炎支原体肺炎诊断中的意义[J].检验医学与临床,2017,14(8):1060-1062.
[12] HE J, LIU M, YE Z, et al. Insights into the pathogenesis of Mycoplasma pneumoniae(Review)[J]. Mol Med Rep, 2016,14(5):4030-4036.
[13] MICHELAKOS T,KONTOS F,BARAKAT O,et al.B7-H3 targeted antibody-based immunotherapy of malignant diseases[J].Expert Opin Biol Ther,2021,21(5):587-602.
[14] 臧瑗,刘亚丽,张中.血浆可溶性B7-H3预测老年肺炎支原体肺炎严重程度的价值[J].实用老年医学,2020,34(7):670-673.
[15] 周楠楠,廖海秀,杨英,等.B7-H3上调IL-22表达在肺腺癌中的临床意义[J].安徽医科大学学报,2021,56(11):1793-1797.
[16] 陈爱年,仲玲玲,王成云.急性脑梗死患者可溶性共刺激分子B7-H3、可溶性细胞间黏附分子-1表达及临床意义[J].中国临床医生杂志,2022,50(5):583-586.
[17] CHO Y J,HAN M S,KIM W S,et al.Correlation between chest radiographic findings and clinical features in hospitalized children with Mycoplasma pneumoniae pneumonia[J].PLoS One, 2019,14(8):1-12.
[18] YANG M,MENG F,WANG K,et al.Interleukin 17A as a good predictor of the severity of Mycoplasma pneumoniae pneumonia in children[J].Sci Rep,2017,7(1):12934-12944.
[19] GU W,ZHANG X,YAN Y,et al.B7-H3 participates in the development of Asthma by augmentation of the inflammatory response independent of TLR2 pathway[J].Sci Rep, 2017,7:40398-40407.
[20] LI Q L,WU Y Y,SUN H M,et al.The role of miR-29c/B7-H3/Th17 axis in children with Mycoplasma pneumoniae pneumonia[J].Ital J Pediatr,2019,45(1):61-70.
[21] SHIOMI A,USUI T,ISHIKAWA Y,et al.GM-CSF but not IL-17 is critical for the development of severe interstitial lung disease in SKG mice[J].J Immunol,2014,193(2):849-859. |